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Canonical non-homologous end joining (c-NHEJ) re-
pairs DNA double-strand breaks (DSBs) in G1 cells
with biphasic kinetics. We show that DSBs repaired
with slow kinetics, including those localizing to het-
erochromatic regions or harboring additional lesions
at the DSB site, undergo resection prior to repair by
c-NHEJ and not alt-NHEJ. Resection-dependent
c-NHEJ represents an inducible process during
which Plk3 phosphorylates CtIP, mediating its inter-
action with Brca1 and promoting the initiation of
resection. Mre11 exonuclease, EXD2, and Exo1
execute resection, and Artemis endonuclease func-
tions to complete the process. If resection does not
commence, then repair can ensue by c-NHEJ, but
when executed, Artemis is essential to complete
resection-dependent c-NHEJ. Additionally, Mre11
endonuclease activity is dispensable for resection
in G1. Thus, resection in G1 differs from the process
in G2 that leads to homologous recombination.
Resection-dependent c-NHEJ significantly contrib-
utes to the formation of deletions and translocations
in G1, which represent important initiating events in
carcinogenesis.
INTRODUCTION
DNA double-strand breaks (DSBs) are repaired by two major
pathways: canonical non-homologous end joining (c-NHEJ) or
homologous recombination (HR) (Jackson and Bartek, 2009;
Lukas and Lukas, 2013). c-NHEJ rejoins DSBs using little or no
sequence homology and functions throughout the cell cycle.
Key players are the Ku70/80 heterodimer and the DNA-depen-
dent protein kinase catalytic subunit (DNA-PKcs), which is
recruited to DNA-bound Ku70/80, generating the DNA-PK holo-
enzyme (Jette and Lees-Miller, 2015). DNA ligase IV (Lig4),Molecular Cell 65, 671–684, Febr
This is an open access article undXRCC4, XRCC4-like factor (XLF)/Cernunnos, and parolog of
XRCC4 and XLF (PAXX) operate during later stages of c-NHEJ
(Ochi et al., 2015). HR is initiated by CtBP-interacting protein
(CtIP)-dependent resection, creating 30 single-stranded DNA
(ssDNA) overhangs at DSB ends (Huertas and Jackson, 2009;
Sartori et al., 2007). HR exerts its major role at stalled or
collapsed replication forks in S phase but also contributes to
DSB repair during G2 (Moynahan and Jasin, 2010).
DSB repair can occur by alternative NHEJ mechanisms,
termed alt-NHEJ (Nussenzweig and Nussenzweig, 2007). alt-
NHEJ involves CtIP-dependent resection, poly-(ADP-ribose)-
polymerases (PARPs), Lig1 or 3 instead of Lig4, and XRCC1
(Lee-Theilen et al., 2011; Wang et al., 2005). CtIP-dependent
end joining occurs in G1 cells (Yun and Hiom, 2009) and contrib-
utes to translocation formation at restriction enzyme- or ionizing
radiation (IR)-induced DSBs (Zhang and Jasin, 2011; Barton
et al., 2014). Polo-like kinase 3 (Plk3) phosphorylates CtIP in
G1, promoting limited end resection and enhancing transloca-
tions (Barton et al., 2014). Thus, various lines of evidence
demonstrate that end resection occurs in G1, although it is
unclear whether the pathway(s) utilizing resected ends are
restricted to alt-NHEJ or include a c-NHEJ process.
IR-induced DSBs are repaired with biphasic kinetics involving
a fast and a slow process (DiBiase et al., 2000; Riballo et al.,
2004). In G1, cells defective in c-NHEJ fail to repair DSBs by
either process (Riballo et al., 2004). In G2, c-NHEJ deficiency af-
fects only the fast process, whereas the slow process represents
HR (Beucher et al., 2009). The slow processes in G1 and G2
repair heterochromatic DSBs (about 15%–20% of all DSBs)
(Goodarzi et al., 2008; Riballo et al., 2004) and require the
Artemis nuclease, suggesting involvement of end-processing
steps (Riballo et al., 2004).
Loss of downstream HR factors (e.g., Brca1, Brca2, Rad51,
and Rad54) diminishes HR, causing unrepaired DSBs in the
slow component in G2 (Beucher et al., 2009; Shibata et al.,
2011). Loss of CtIP also abolishes HR in G2 because resection
is not initiated. However, it does not result in unrepaired DSBs
because c-NHEJ, which is normally restricted to the fast compo-
nent in G2, can repair unresected breaks (Shibata et al., 2011).
Thus, a repair factor may function in the repair process evenuary 16, 2017 ª 2016 The Author(s). Published by Elsevier Inc. 671
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though its loss does not confer a repair defect (e.g., CtIP in G2).
This is important because CtIP depletion does not cause a repair
defect in G1 but strongly diminishes chromosome translocations
(Barton et al., 2014). Therefore, we considered the possibility
that the slow process in G1 represents a resection-dependent
process (as in G2) and that preventing resection by CtIP deple-
tion causes a pathway switch from resection-dependent to
resection-independent c-NHEJ, explaining the lack of a repair
defect and reduced chromosome translocations (making the
assumption that resected DSBs are more prone to undergo
mis-rejoining than unresected DSBs).
We clarify this provocative possibility and verify that the slow
repair component in G1 represents a resection-dependent re-
joining process. The process utilizes c-NHEJ and not alt-NHEJ
factors. Thus, the two main repair processes in G1 human cells
are resection-independent and resection-dependent c-NHEJ.
Resection-dependent c-NHEJ avidly forms IR-induced translo-
cations, highlighting its physiological relevance. We then investi-
gated the factors regulating resection-dependent c-NHEJ and
identified striking differences to the resection process in G2.
First, resection-dependent c-NHEJ is initiated after DSB induc-
tion by Plk3, which phosphorylates CtIP at Ser327 to mediate
CtIP-Brca1 interaction. Thus, in contrast to G2, where cyclin-
dependent kinases (CDKs) constitutively phosphorylate CtIP,
the initiation of resection in G1 is inducible. Following initiation
by Plk3/CtIP/Brca1, Mre11 exonuclease, EXD2, and Exo1
execute resection, and Artemis completes the process. Mre11
endonuclease activity is dispensable for resection in G1, sug-
gesting that resection commences from the DSB end and not
internally as in G2 (Shibata et al., 2014). Our findings reveal differ-
ences in resection between G1 and G2, enhancing our under-
standing of DSB repair in human cells and facilitating the design
of approaches to reactivate HR in G1 for gene targeting
(Orthwein et al., 2015).
RESULTS
Slow Artemis-Dependent c-NHEJ Promotes
Translocation Formation in G1
We enumerated translocations forming in G1 human fibroblasts
by premature chromosome condensation (PCC) combined with
fluorescence in situ hybridization (FISH). We harvested asyn-
chronous 82-6 fibroblasts at defined times after X-ray IR (X-IR)
and fused them with mitotic HeLa cells to promote PCC of fibro-
blast chromosomes. G1 PCC spreads were distinct from G2
spreads and from mitotic HeLa cells by their one-chromatid
morphology and the G1-specific marker CDT1 (Nishitani et al.,
2001). PCC spreads from S phase cells displayed massive chro-
mosome breakage and were also excluded from the analysis
(Gotoh and Durante, 2006). Nocodazole was added to prevent
G2 cells from entering G1, and control experiments confirmed
that cells were irradiated and maintained in G1 (Figures S1 and
S2A–S2C). We stained chromosomes 1, 2, and 4 by FISH and
identified chromosome breaks as stained fragments and translo-
cations by the appearance of chromosomes with color junctions
(Figure 1A). Chromosome breaks were rejoined with biphasic
kinetics (Figure 1B), consistent with DSB rejoining assessed by
gH2AX analysis or pulsed field gel electrophoresis (Riballo672 Molecular Cell 65, 671–684, February 16, 2017et al., 2004). Some translocations formed within 6 hr after X-IR,
when most chromosome breaks were repaired. However, be-
tween 6 and 14 hr after X-IR, translocations doubled, but few
breaks were repaired, demonstrating that the slow process is
particularly error-prone (Figure 1C; Barton et al., 2014).
To investigate the process causing translocations, we treated
cells with a PARP inhibitor or small interfering RNA (siRNA)
Lig1/3 (siLig1/3) but found no effect on chromosome break repair
or translocation formation (Figures1Band1C), demonstrating that
X-IR-induced translocations in G1 human cells do not form by
alt-NHEJ. Next, we added a DNA-PK inhibitor 6 hr after X-IR
(when the fast repair component is completed) and observed
elevated chromosome breaks and diminished translocations
14hr after X-IR comparedwith untreated cells (Figure 1D). Indeed,
translocation levels after DNA-PK inhibitor addition at 6 hr are
only slightly increased compared with translocations arising in
the first 6 hr when DNA-PKcs was active. This suggests that a
slow c-NHEJ process involving DNA-PKcs substantially contrib-
utes to X-IR-induced chromosome translocation formation.
Because Artemis is essential for slow DSB repair, we next car-
ried out combined PCC/FISH analysis in Artemis-deficient fibro-
blasts. We observed elevated unrepaired breaks and diminished
translocations 14 but not 6 hr after X-IR (Figure 1E). Thus,
Artemis deficiency specifically affects the slow component of
translocation formation, confirming that such translocations
arise from the slow DSB repair process.
To confirm that the slow Artemis-dependent translocations
arise from c-NHEJ, we employed a semi-automated micro-
scopic approach that assesses repair kinetics by gH2AX focus
analysis in defined cell-cycle phases (Figure S2D). First, we
investigatedDNA-PK involvement during the slow repair process
in G1. Using 7 Gy, the same dose used for translocation mea-
surements, we added the DNA-PK inhibitor 6, 8, 10, and 12 hr af-
ter X-IR and analyzed gH2AX foci at 14 hr in G1 cells. Inhibitor
addition at all time points strongly impaired DSB repair, consis-
tent with the notion that DNA-PK is bound to break ends
throughout the slow repair process (Figure 1F). Furthermore,
PARP inhibition did not affect gH2AX focus levels 14 hr after
X-IR in control, XLF-deficient or Lig4-mutated fibroblasts (Fig-
ure 1G), although it increased focus numbers in HeLa cells
treated with siKu80 (Figure S2E).
To confirm that DNA-PK and Artemis operate in the same slow
repair process, we added the DNA-PK inhibitor to G1 phase
Artemis-deficient and control fibroblasts. Using 2 Gy, we added
the inhibitor 4 hr after X-IR (when the fast DSB repair process had
completed) and scored gH2AX foci 8 and 10 hr after X-IR. Of
note, DNA-PK inhibition did not affect the focus level of
Artemis-deficient cells but increased focus numbers in control
cells to that of Artemis-deficient cells, demonstrating that
DNA-PK and Artemis function during slow DSB repair (Fig-
ure 1H). Collectively, we show that the slow Artemis-dependent
component of translocation formation and DSB repair repre-
sents a c-NHEJ process and that human cells do not employ
alt-NHEJ as long as Ku is present.
Artemis and CtIP Function during SlowDSBRepair in G1
The generation of X-IR-induced translocations in human cells by




Figure 1. A Slow Artemis-Dependent c-NHEJ Process Promotes Translocation Formation in G1
(A) Left: FISH-stained G1 PCC spread from 82-6 control cells (dashed circle) fused with mitotic HeLa cells. Right: chromosome breaks and translocations in G1
PCC spreads.
(B and C) Chromosome breaks (B) and translocations (C) in G1 82-6 cells treated with siLig1/3 or PARP inhibitor (PARPi). Data are mean ± SEM.
(D) Chromosome breaks and translocations in G1 82-6 cells treated with DNA-PK inhibitor (DNA-PKi) 6 hr after X-IR. Data are mean ± SEM.
(E) Chromosome breaks and translocations in G1 82-6 and Artemis-deficient CJ179 cells. Data are mean ± SEM.
(F) gH2AX foci in G1 82-6 cells treated with DNA-PKi at various times after X-IR. Data are mean ± SEM.
(G) gH2AX foci in G1 82-6, XLF-deficient 2BN and Lig4-mutated 411Br cells treated with PARPi. Data are mean ± SEM.
(H) gH2AX foci in G1 82-6 and CJ179 cells treated with DNA-PKi 4 hr after X-IR. Data are mean ± SEM.
See also Figures S1 and S2.





Figure 2. Artemis and CtIP Function during
Slow DSB Repair and Promote Resection
in G1
(A) gH2AX foci in G1 82-6 and CJ179 cells treated
with siCtIP. Data are mean ± SEM.
(B) gH2AX foci in CJ179 cells treated with siCtIP.
Cells were transfected with GFP or GFP-CtIP-WT
constructs, and gH2AX foci were analyzed in GFP+
G1 cells. Data are mean ± SEM.
(C) Chromosome breaks in G1 82-6 and CJ179
cells treated with siCtIP. Data are mean ± SEM.
(D) pRPA foci in G1 HeLa cells treated with
siArtemis. Cells were transfected with GFP or
cMyc-Artemis plasmids, and foci were analyzed in
GFP/cMyc+ G1 cells. Data are mean ± SEM.
(E) pRPA foci in G1 GC92 WT and CRISPR/Cas9-
generated Artemis KO cells. Cells were trans-
fected with GFP or cMyc-Artemis constructs, and
pRPA foci were analyzed in GFP/cMyc+ G1 cells.
Data are mean ± SEM.
(F) pRPA foci in G1 GC92WT and Artemis KO cells
treated with siCtIP. Data are mean ± SEM.
See also Figure S3.employing designer nucleases (Ghezraoui et al., 2014). We
observed previously that CtIP contributes to the slow compo-
nent of X-IR-induced translocations in G1 human cells, although
the underlying repair pathway was not examined (Barton et al.,
2014). This raised the possibility that the slow c-NHEJ process
in G1 involves Artemis and CtIP. Therefore, we measured the
kinetics of DSB repair in siCtIP-depleted G1 fibroblasts. In
wild-type (WT) cells, we observed similar gH2AX focus numbers
at all times, analyzed with or without siCtIP (Figure 2A; Barton
et al., 2014). In G2, siCtIP abolishes resection and HR but does674 Molecular Cell 65, 671–684, February 16, 2017not cause a repair defect because
c-NHEJ can be used if resection is not
initiated. Consequently, co-depletion of
CtIP/Brca1 or CtIP/Brca2 relieves the
repair defect caused by loss of Brca1 or
Brca2, respectively (Kakarougkas et al.,
2013; Shibata et al., 2011).
Thus, we considered that siCtIP might
similarly cause a switch from a resec-
tion-dependent to a resection-indepen-
dent process in G1. Because Artemis is
essential for the slow repair process in
G1, as are Brca1 and Brca2 in G2, we
examined whether siCtIP affects repair
in Artemis mutants in G1. As expected,
we observed the same level of gH2AX
foci in Artemis-deficient and control fibro-
blasts at 15 min and 2 hr but higher levels
in Artemis-deficient fibroblasts 8 and
10 hr after X-IR (Figure 2A). Strikingly,
siCtIP rescued the repair defect of G1
Artemis mutants (Figure 2A), and overex-
pression of siRNA-resistant GFP-tagged
CtIP in siCtIP-treated Artemis mutants
restored the repair defect (Figure 2B). Asimilar rescue by siCtIP was observed in another cell system
(Figure S3A). We conclude that Artemis and CtIP function
during slow DSB repair in G1. The finding that Artemis but not
CtIP deficiency confers a repair defect strongly suggests that
Artemis functions downstream of CtIP, reflective of the situation
in G2, where several factors (e.g., Brca1 and Brca2) function
downstream of CtIP to promote HR and that their combined
depletion with CtIP rescues their repair defects. This was
confirmed by investigating chromosome breaks in G1 cells using
PCC/FISH. We observed similar initial breakage levels for all
conditions, a pronounced repair defect in Artemis-deficient
fibroblasts 8 and 10 hr after X-IR, and rescue by siCtIP (Fig-
ure 2C). In conclusion, Artemis and CtIP function during slow
DSB repair, which confirms our translocation measurements
and shows that this DSB repair process causes slow transloca-
tion formation.
Artemis and CtIP Promote Resection in G1
To gain direct evidence for resection during slow DSB repair in
G1, we examined phospho-replication protein A (pRPA) foci by
immunofluorescence using our semi-automated microscopic
approach (Figure S2D). Because pRPA foci are difficult to detect
after X-IR in G1, we exploited a particle IR (a-IR), which induces
multiple damages in close proximity, creating complex DSBs.
DSB end complexity impedes NHEJ and slows DSB repair,
which promotes resection, pRPA focus formation, and HR usage
in G2 (Barton et al., 2014; Shibata et al., 2011).
Indeed, pRPA foci are readily observed in G1 2 and 6 hr after
a-IR and require CtIP (Barton et al., 2014). siArtemis reduced
pRPA focus numbers (Figure 2D), demonstrating that Artemis
and CtIP promote resection in G1. We transfected Artemis-
depleted cells with siRNA-resistant cMyc-tagged Artemis con-
structs and enumerated pRPA foci in cMyc+ G1 cells. WT but
not nuclease-deficient Artemis restored the resection defect
conferred by siArtemis (Figure 2D). We also generated an
Artemis knockout (KO) cell line by CRISPR/Cas9 technology
and observed fewer pRPA foci in G1 Artemis KO cells than in
control cells. The diminished focus level was restored by WT
but not nuclease-defective Artemis (Figure 2E). The resection
defect in Artemis KO cells was similar to that of siCtIP cells,
and siCtIP in Artemis KO cells caused no further defect (Fig-
ure 2F). Finally, assessment of ssDNA in G1 cells by enumerating
bromodeoxyuridine (BrdU) foci confirmed that Artemis is
required for resection (Figure S3B). To confirm that resection
after a-IR represents the same Artemis/CtIP-dependent slow
c-NHEJ pathway uncovered in the Artemis rescue experiments,
we examined gH2AX foci after a-IR in G1. We observed delayed
repair kinetics compared with X-IR and a requirement for Artemis
and CtIP (Figure S3C; Barton et al., 2014). Moreover, DNA-PK
but not PARP inhibition conferred a repair defect (Figure S3C).
Given the slow kinetics, Artemis requirement, and PARP inde-
pendence, the repair of a-IR-inducedDSBs appears to represent
the same c-NHEJ pathway that repairs 15%–20% of DSBs
after X-rays.
We alsomeasured pRPA foci after 20-Gy X-rays, a dose giving
similar focus numbers as 2-Gy a-IR. siArtemis and siCtIP
reduced pRPA levels as for a-IR (Figure S3D). We then examined
whether Ku was retained at resected DSBs by co-staining
against pRPA and Ku80. Strikingly, although the samples
showed significant Ku80 background staining, nearly every G1
pRPA focus co-localized with a Ku80 focus (Figure S3E). As a
control, we co-stained Ku80 and Rad51 in G2 cells using the
same conditions (20 Gy, 4 hr) plus a lower dose at a later time
point (4 Gy, 8 hr). We rarely observed co-localization of Ku80
and Rad51, demonstrating antibody specificity (Figure S3F).
Importantly, a recent paper showed that Ku is removed from re-
sected DSBs in G2 concomitant with Rad51 loading (Chanut
et al., 2016). We conclude that Artemis nuclease, together withCtIP, promotes DSB resection in G1, although the extent of
resection is more limited than in G2 because detecting pRPA re-
quires high doses or complex DSBs. We further propose that Ku
remains bound during resection in G1.
Molecular Characterization of G1 Resection
To molecularly characterize the Artemis- and CtIP-dependent
resection process, we employed a reporter assay containing
two I-SceI restriction sites located 3.2 kilobase pairs (kbp) apart.
Joining of the distant DSB ends causing loss of the intervening
fragment was monitored (Figure 3A). The joining events arise in
G1 (Barton et al., 2014) and require CtIP (Rass et al., 2009), sug-
gesting that they necessitate some level of resection. Thus, we
examined whether this assay selectively monitors the resec-
tion-dependent slow repair process. We first enumerated
gH2AX foci that arise following I-SceI transfection. Control
cells showed no significant focus induction over background,
whereas siDNA-PKcs or usage of Artemis KO cells increased
focus numbers (Figure 3B), suggesting that repair of these
I-SceI-induced DSBs requires Artemis and DNA-PKcs. Notably,
siCtIP had no effect in control cells but reduced the elevated
focus numbers observed in Artemis KO cells (Figure 3B). This re-
capitulates our findings after X-IR, suggesting that this assay
monitors the slow DSB repair process. Next, we used the
Artemis KO cells containing the reporter and observed a com-
plete reduction of end joining events involving loss of the
3.2-kbp fragment, which was restored by WT but not
nuclease-deficient Artemis (Figure 3C). siCtIP reduced end
joining events in control but not in Artemis KO cells (Figure 3D).
Collectively, these findings show that the diminished end joining
events in Artemis KO cells arise because of unrepaired DSBs,
whereas siCtIP reduces end joining involving loss of the inter-
vening fragment at the expense of events that escape detection
in the assay (Figure 3A). Sequence analysis of the repair junc-
tions in control cells revealed that loss of the intervening frag-
ment is often associated with additional deletions (consistent
with the notion that this assay monitors resection-dependent
end joining) and frequently involves micro-homology usage (Fig-
ure 3E; Table S1).
We also investigated the role of alt-NHEJ and c-NHEJ in this
reporter assay. Depletion of Ku increased the frequency of
events (Figure 3F), consistent with the observation that alt-
NHEJ can effect rejoining without Ku (Guirouilh-Barbat et al.,
2004). In contrast, siDNA-PKcs and siLig4 substantially reduced
end joining, whereas siLig1/3 had no significant effect on rejoin-
ing frequency, deletion size, or micro-homology usage (Figures
3E and 3F; Table S1). These data demonstrate that this reporter
assay monitors a c-NHEJ process and that alt-NHEJ has no
significant role in Ku-proficient cells. Thus, the reporter assay
confirms the results obtained from the analysis of DSB repair
pathway usage after IR.
Similar and Distinct Nuclease Requirements for
Resection in G1 versus G2
Having established that Artemis and CtIP promote a resection-
dependent slow NHEJ process in G1, we examined whether
resection proceeds similar to that in G2. First, we asked which
additional nucleases execute resection in G1 and investigatedMolecular Cell 65, 671–684, February 16, 2017 675
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Figure 3. Molecular Characterization of G1 Resection
(A) Schematic of the NHEJ reporter assay. The repair of two I-SceI-induced DSBs can result in loss of the intervening fragment, which is detected by aCD4+ signal
(Rass et al., 2009). CD4+ cloneswere amplified by PCR (green arrows) across the repair site and sequenced. Repair of the twoDSBs can also occur without loss of
the intervening fragment, which escapes detection.
(B) gH2AX foci in GC92WT andArtemis KO cells treatedwith siDNA-PKcs or siCtIP. Cells were transfectedwith I-SceI, and foci were scored in I-SceI+ and I-SceI
cells (identified by immunofluorescence [IF] against I-SceI). Data are mean ± SEM.
(C) End joining events in GC92 WT and Artemis KO cells containing the NHEJ reporter substrate. Cells were transfected with RFP or cMyc-Artemis constructs.
Events were quantified by the fraction of CD4+ andRFP/cMyc+cells relative to all RFP/cMyc+cells, and results were normalized toWT cells. Data aremean ± SEM.
(D) End joining events in GC92 WT and Artemis KO cells treated with siCtIP. Data are mean ± SEM.
(E) Distribution of deletion sizes obtained from the sequence analysis of GC92 WT and siLig1/3-treated cells. nt, nucleotide.
(F) End joining events in GC92 cells treated with siKu70/80, siLig4, siLig1/3, or siDNA-PKcs. Data are mean ± SEM.
See also Table S1.Mre11, EXD2, Exo1, and Bloom syndrome mutated protein
(BLM)/DNA2. We applied the three approaches described in Fig-
ures 2 and 3 to monitor resection-dependent slow NHEJ, as-
sessing rescue of the Artemis repair defect in G1, pRPA focus
formation in G1, and G1-specific end joining events in the re-
porter assay. BecauseMre11 is required to activate ataxia telan-
giectasia mutated (ATM), its loss causes a repair defect in this
process (Riballo et al., 2004), precluding analysis by siRNA.
We therefore inhibited Mre11 nuclease activities by small-mole-
cule inhibitors that selectively target its endo- or exonuclease ac-
tivities (Shibata et al., 2014) without affecting ATM activation
(Figure S4A). Inhibition of Mre11’s endonuclease activity did
not affect the gH2AX focus or chromosome break level of
Artemis-deficient cells (Figure 4A; Figure S4B), pRPA levels (Fig-676 Molecular Cell 65, 671–684, February 16, 2017ure 4B; Figure S3D), and the frequency of end joining in the
reporter assay (Figure 4C). In contrast, inhibition of Mre11’s
exonuclease activity partially rescued the repair defect of
Artemis-deficient cells (Figure 4A; Figure S4B), diminished the
pRPA focus level (Figure 4B; Figure S3D), and reduced the fre-
quency of end joining in the reporter assay (Figure 4C). These
data suggest that Mre11 functions during resection in G1 as an
exonuclease, whereas its endonuclease activity is dispensable.
This differs from G2, where Mre11 endonuclease inhibition abol-
ishes HR in a reporter assay (Figure S4C) and rescues the repair
defect of Artemis-deficient cells (Figure S4D).
Examining Exo1’s function, we obtained results nearly iden-
tical to Mre11 exonuclease inhibition. Specifically, siExo1




Figure 4. Similar and Distinct Nuclease Requirements for Resection in G1 versus G2
(A–C) gH2AX foci in G1 82-6 and CJ179 cells (A), pRPA foci in G1 HeLa cells (B), and end-joining events in GC92 cells (C). Cells were treated with anMre11 endo-
or exonuclease inhibitor, siEXD2, siExo1, or siBLM/siDNA2. Data are mean ± SEM.
(legend continued on next page)
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(Figure 4A; Figure S4B), diminished the pRPA focus level (Fig-
ure 4B; Figure S3D), and reduced end joining in the reporter
assay (Figure 4C). Expression of siRNA-resistant FLAG-tagged
Exo1 restored the defect in Artemis-deficient cells treated with
siExo1 and end joining in siExo1-treated cells in the reporter
assay (Figure 4D). Additionally, siEXD2 had the same effect in
our three assays as siExo1 or Mre11 exonuclease inhibition,
whereas combined depletion of BLM and DNA2 was without ef-
fect (Figures 4A–4C). Collectively, these data show that the 50-30
exonuclease activity of Exo1 (Lee andWilson, 1999) and the 30-50
exonuclease activities of Mre11 (Paull and Gellert, 1998) and
EXD2 (Broderick et al., 2016) promote limited resection at slowly
repairing DSBs in G1. Given that DNA-PKcs inhibition blocks the
slow repair process and that Ku is required for DNA-PKcs bind-
ing, we propose that Ku70/80 remains bound to DSBs during
resection, moving away from the break ends to expose DNA
ends for nuclease access while limiting the extent of resected
DNA (Figure 4E). This model is consistent with our analysis of
Ku foci in G1 (Figure S3E). This suggests that resection in G1 is
distinct from G2, where Mre11’s endonuclease activity is pro-
posed to initiate resection internal to the break end, followed
by resection toward and away from the end by Mre11 exonu-
clease and Exo1, respectively (Figure 4E; Shibata et al., 2014).
Consistent with this model, loss of Mre11 exonuclease activity
or Exo1 causes a repair defect in G2 because the incompletely
resected DSBs cannot be repaired by HR or NHEJ (Figure S4D).
Brca1 and 53BP1 Together Promote Resection-
Dependent Slow DSB Repair in G1
Because Brca1 promotes resection in G2, we investigated
whether it is also required for resection in G1 by applying our
three assays. Using human fibroblasts, we observed that
siBrca1 did not cause a repair defect in control cells but substan-
tially rescued the defect of Artemis-deficient cells (Figure 5A;
Figure S4B). We also observed diminished pRPA foci after
siBrca1 (Figure 5B; Figure S3D) and reduced end joining in the
reporter assay (Figure 5C). Expression of siRNA-resistant
FLAG-tagged Brca1 restored the repair defect in siBrca1-treated
Artemis-deficient cells and end joining in siBrca1-treated cells in
the reporter assay (Figure 5D). Because loss of 53BP1 relieves
the repair defect of Brca1 mutants in G2, we asked whether
si53BP1 affects resection following siBrca1. Of note, combined
si53BP1 and siBrca1 treatment increased pRPA focus numbers
(Figure 5B) and end joining in the reporter assay (Figure 5C) to the
level conferred by si53BP1 alone. This shows that Brca1 func-
tions during resection-dependent c-NHEJ by counteracting
53BP1, similar to its described function during HR. Interestingly,
si53BP1 led to increased pRPA foci numbers (Figure 5B) and
elevated end joining events in the reporter assay (Figure 5C)
compared with control cells, which were reduced to control
levels after expression of siRNA-resistant HA-tagged 53BP1
(Figure S5A). This suggests that resection in the absence of
53BP1 is less restricted than in control cells. Significantly,(D) gH2AX foci in G1 CJ179 and end joining events in GC92 cells. Cells were treat
and GFP+, RFP+ or FLAG+ cells were analyzed. Data are mean ± SEM.
(E) Model for DSB end resection in G1 and G2. DNA-PKcs binding to Ku was om
See also Figure S4.
678 Molecular Cell 65, 671–684, February 16, 2017depletion of Lig1/3 in si53BP1-treated cells nearly completely
abolished end joining events in the reporter assay (Figure S5B),
arguing that the repair process in 53BP1-defective cells differs
from the resection-dependent c-NHEJ pathway described
here. This is reminiscent of the situation in G2, where loss of
53BP1 channels DSB repair from gene conversion to single-
strand annealing (Ochs et al., 2016). Thus, 53BP1 promotes
resection-dependent c-NHEJ by regulating the extent of
resection.
We next examined mouse embryonic fibroblasts (MEFs) car-
rying either Brca1-WT or Brca1-DBRCT, which lacks the interac-
tion site with CtIP (Kakarougkas et al., 2013). siArtemis caused a
repair defect in Brca1-WT but not Brca1-DBRCT MEFs (Fig-
ure 5E), which is rescued by siRNA-resistant cMyc-tagged
Artemis (Figure S5C). We also observed diminished pRPA foci
in Brca1-DBRCT compared with Brca1-WT MEFs (Figure 5F).
To consolidate these functional studies, we measured Brca1
focus formation. We confirmed that Brca1 accumulation at
DSBs after X-IR is visible but weaker in G1 compared with G2
(Figure S5D; Chapman et al., 2013; Escribano-Dı´az et al.,
2013; Feng et al., 2013). However, both G1 and G2 cells showed
robust Brca1 accumulation at a-IR-induced DSBs (Figure S5E).
Collectively, this suggests that Brca1 functions during resec-
tion-dependent slow DSB repair in G1 in a manner requiring its
BRCA1 C-terminal (BRCT) domain. Furthermore, loss of Brca1
in G1 (unlike in G2) does not cause a DSB repair defect, demon-
strating that it determines pathway choice in G1 but functions
downstream of that step in G2.
Plk3 Promotes Resection-Dependent Slow DSB Repair
in G1
Because Plk3 regulates CtIP in G1 (Barton et al., 2014), we
investigated its role during slow repair in G1. We observed
that, like siCtIP, siPlk3 does not cause a DSB repair defect
but rescues the defect of siArtemis-treated HeLa cells (Fig-
ure 6A). Expression of siRNA-resistant FLAG-tagged Plk3
restored the repair defect in Artemis/Plk3-depleted cells (Fig-
ure 6B). siPlk3 in G2, where Plk3 is dispensable for CtIP
regulation, did not rescue the defect of siArtemis-treated cells
(Figure S6A). We confirmed these results with fibroblasts using
siPlk3 and a Plk3 inhibitor (Plki) (Lansing et al., 2007; Fig-
ure S6B). Because Plk3 phosphorylates CtIP in G1 at Ser327
(Barton et al., 2014), we asked whether this phosphorylation
event is required during resection-dependent repair. We co-
depleted Artemis and CtIP in HeLa cells, transfected them
with siRNA-resistant GFP-CtIP constructs, and enumerated
gH2AX foci in G1. Notably, GFP-CtIP-WT and a phospho-mimic
substitution at Ser327 (GFP-CtIP-S327E), but not a non-phos-
phorylatable mutant (GFP-CtIP-S327A), restored the Artemis
repair defect in Artemis/CtIP-depleted cells (Figure 6C). The
same result was obtained with fibroblasts (Figure S6C), confirm-
ing that CtIP phosphorylation at Ser327 is necessary for resec-





Figure 5. Brca1 and 53BP1 Together Promote Resection-Dependent Slow DSB Repair in G1
(A) gH2AX foci in G1 82-6 and CJ179 cells treated with siBrca1. Data are mean ± SEM.
(B) pRPA foci in G1 HeLa cells treated with si53BP1 and/or siBrca1. Data are mean ± SEM.
(C) End joining events in GC92 cells treated with si53BP1 and/or siBrca1. Data are mean ± SEM.
(legend continued on next page)
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Figure 6. Plk3 Is Required for Resection-Dependent Slow DSB
Repair in G1
(A) gH2AX foci in G1 HeLa cells treated with siArtemis and/or siPlk3. Data are
mean ± SEM.
(B) gH2AX foci in G1 HeLa cells treated with siArtemis/siPlk3 and transfected
with GFP or FLAG-Plk3-WT constructs, and GFP+ or FLAG+ G1 cells were
analyzed. Data are mean ± SEM.
(C) gH2AX foci in G1HeLa cells treatedwith siArtemis and/or siCtIP. Cells were
transfected with GFP or GFP-CtIP constructs, and GFP+ G1-phase cells were
analyzed. Data are mean ± SEM.
See also Figure S6.CtIP Phosphorylation at Ser327 by Plk3 Mediates
Interaction with Brca1 in G1
CtIP phosphorylation at Ser327 by CDKs in G2 mediates its
interaction with Brca1 (Yu and Chen, 2004). Although this phos-
phorylation occurs constitutively in undamaged G2 cells, CtIP
phosphorylation by Plk3 in G1 is only observed after IR (Barton(D) gH2AX foci in G1 CJ179 and end joining events in GC92 cells. Cells were treate
and GFP+, RFP+ or FLAG+ cells were analyzed. Data are mean ± SEM.
(E) gH2AX foci in G1 Brca1-WT and Brca1-DBRCT MEFs treated with siArtemis.
(F) pRPA foci in G1 Brca1-WT and Brca1-DBRCT MEFs. Data are mean ± SEM.
See also Figure S5.
680 Molecular Cell 65, 671–684, February 16, 2017et al., 2014). Because CtIP phosphorylation at Ser327 and
Brca1’s BRCT domain, which encompasses the CtIP interaction
site, are required for slow repair in G1, we examined whether
Brca1 and CtIP physically interact in G1 using co-immunopre-
cipitation analysis in synchronized G1 HeLa cells (Figure S7A).
We confirmed that CtIP phosphorylation at Ser327 is only
observed after IR and that Plki abolished the IR-induced signal
(Figure 7A; Barton et al., 2014). Notably, Brca1 co-immunopre-
cipitated with CtIP closely followed the CtIP phosphorylation
signal at Ser327; that is, it was absent in unirradiated samples,
appeared 1 hr after IR, and was absent when the samples
were treated with Plki (Figure 7A). In the reverse experiment,
we observed strong levels of CtIP co-immunoprecipitated with
Brca1 1 hr after IR only in non-Plki treated samples (Figure 7A).
This analysis shows that CtIP and Brca1 physically interact in
G1 in a damage-inducible manner that requires Plk3.
We next examined whether the damage-inducible CtIP-Brca1
interaction in G1 depends on CtIP phosphorylation at Ser327.
We transfected HeLa cells with GFP-CtIP-WT or non-phosphor-
ylatable GFP-CtIP-S327A, irradiated them or not, and immuno-
precipitated GFP. The transfection stress caused >90% of the
GFP-positive HeLa cells to arrest in G1 (Figure S7B). In cells
transfected with GFP-CtIP-WT, we observed pronounced CtIP
phosphorylation at Ser327 1 hr after IR but not without IR (Fig-
ure 7B). Brca1 did not co-immunoprecipitate with GFP-CtIP in
unirradiated cells, but a robust signal was observed 1 hr after
IR. Cells transfected with GFP-CtIP-S327A showed no CtIP
phosphorylation at Ser327 and no detectable Brca1 (Figure 7B).
Conversely, we detected a strong signal for GFP-CtIP co-immu-
noprecipitated with Brca1 in the irradiated GFP-CtIP-WT but not
the GFP-CtIP-S327A sample (Figure 7B). These data show that
CtIP and Brca1 physically interact in G1 in a damage-inducible
manner dependent on CtIP phosphorylation at Ser327.
DISCUSSION
DSB resection can arise in G1 as well as S and G2, and Rad51
binding to extended ssDNA regions can occur in genetically
manipulated G1 cells (Orthwein et al., 2015). However, Rad51
loading to ssDNA does not normally occur in G1, and resection
is too limited to detect RPA binding microscopically, limiting
our ability to study resection in G1.
Our study was initiated by the finding that CtIP depletion res-
cues the repair defect of Artemis mutants. Artemis is required for
the slow DSB repair process that, after X-IR, repairs DSBs local-
izing to heterochromatic DNA regions. This has provided a
readout to probe the role of additional factors for G1 resection.
We reasoned that resection occurs in heterochromatin because
repair is delayed (Goodarzi et al., 2008). Additionally, to study
resection in G1, we utilized a-IR, which induces complex DSBs
that are repaired with slow kinetics and undergo resection in
G2 (Shibata et al., 2011). In G1, DSBs induced by a-IR gived with siBrca1 and transfected with GFP, RFP or FLAG-Brca1-WT constructs,
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Figure 7. CtIP Phosphorylation at Ser327 by
Plk3 Mediates Interaction with Brca1 in G1
(A) Interaction of CtIP and Brca1 in synchronized
G1 HeLa cells treated with Plki.
(B) Interaction of CtIP and Brca1 in G1 HeLa cells
transfected with GFP-CtIP-WT or GFP-CtIP-
S327A. Brca1 or GFP/CtIP was immunoprecipi-
tated from cell extracts, and protein levels were
analyzed.
(C) Model summarizing the hierarchy of investi-
gated factors involved in resection-dependent
c-NHEJ in G1 in comparison with HR in G2.
(D) Model for DSB repair pathway choice in G1
human cells.
See also Figure S7.rise to CtIP-dependent pRPA foci (Barton et al., 2014). This sec-
ond approach fully consolidated the findings obtained with the
Artemis rescue experiments.
As a third approach to study resection in G1, we used a re-
porter assay containing two I-SceI restriction sites that monitors
end joining of the two distant ends with loss of the intervening
fragment (Rass et al., 2009). We considered that such events
represent slow DSB repair, whereas fast repair may promote
end joining events without loss of the intervening fragment that
escape detection in the assay. Because slow DSB repair in-
volves resection, we reasoned that this assay might specifically
monitor resection-dependent end joining. Thus, we exploited
three independent methods to study resection-dependent slow
DSB repair in G1. The reporter assay additionally revealed that
resection-dependent end joining is associated with nucleotide
losses of 5–20 bp, although the extent of resection might be
larger for a-IR-induced DSBs.
Using these three approaches, we characterized the resec-
tion process in G1, revealing differences from G2 resectionMolecula(Figure 7C). First, we showed that (as in
G2 phase) the slow component of DSB
repair in G1 represents a resection-
dependent repair process. This is signifi-
cant because previous work has estab-
lished that slow DSB repair involves the
c-NHEJ factors Lig4, XRCC4, and XLF
(Beucher et al., 2009; Riballo et al.,
2004). Here we show that DNA-PKcs inhi-
bition at later times (when the fast repair
process is completed) stops repair in
G1, suggesting that DNA-PK is required
for the slow process. This is distinct
from the situation in G2, where DNA-PK
is removed during resection. Thus, the
slow component of DSB repair involves
resection in G1 and G2, but, in G1, repair
occurs via c-NHEJ, whereas, in G2, HR
effects repair.
A second difference between resection
in G1 versus G2 likely explains how DNA-
PK binding to resected DSBs is main-
tained in G1 but prevented in G2.Although Mre11 initiates resection in G2 as an endonuclease in-
ternal to the DSB, this function ofMre11 is dispensable for resec-
tion in G1. Thus, it is likely that resection in G1 initiates from the
DSB end by the exonuclease functions of Mre11, EXD2, and
Exo1, which, because of their different polarity, can resect one
or the other DNA strand. An interesting model is that Ku remains
bound to the DSBs but moves away from the ends to allow
nuclease access (i.e., translocates inward, a feature well
described in biochemical studies; Turchi et al., 2000). In G2, in
contrast, nucleolytic incision on the 50 strand internal to the
DSB is followed by resection toward and away from the DSB
by the exonuclease functions of Mre11/EXD2 and Exo1, respec-
tively. After removal of DNA-PK by still unknown processes, the
large region of ssDNA likely prevents DNA-PK re-binding.
Notably, maintained DNA-PK binding to DSBs during resection
in G1 but not G2 (Figure 1F; Figure S3E) could also explain the
more limited resection in G1.
The third difference between resection in G1 and G2 concerns
the initiation step. In G2, CtIP is constitutively phosphorylated byr Cell 65, 671–684, February 16, 2017 681
CDKs at Ser327,mediating interactionwith Brca1 and promoting
HR (Yu et al., 2006; Yun and Hiom, 2009), although the latter
notion has been challenged (Reczek et al., 2013). Brca1 counter-
acts the anti-resection functions of 53BP1 and Rif1 (Chapman
et al., 2013; Escribano-Dı´az et al., 2013; Feng et al., 2013). In
G1, IR activates Plk3, which phosphorylates CtIP at Ser327 (Bar-
ton et al., 2014). Hence, CtIP interacts with Brca1 in G1 only after
damage induction. Because the CtIP interaction domain of
Brca1 is required for resection, Brca1’s role in promoting
resection may be transiently kept in check to allow resection-
independent c-NHEJ before activating the more error-prone
resection-dependent c-NHEJ process.
Our findings also reveal distinctions in the commitment step to
resection-dependent repair between G1 and G2 (Figure 7C).
Depletion of Brca1 (and also Exo1 and Mre11 exonuclease)
causes a repair defect in G2 because Brca1 lies downstream
of CtIP-dependent initiation of resection (Kakarougkas et al.,
2013). In contrast, Brca1 depletion does not cause a defect in
G1, suggesting that it is required for the initiation process, which,
if prevented, allows rejoining without resection. This might also
explain the controversy concerning Brca1’s role in G1 (because
the assays used may or may not be specific for the described
resection-dependent process) (Wu et al., 2010). Interestingly,
our results show that Brca1 relieves a 53BP1 barrier to resection,
defining a hitherto undescribed role for Brca1 in G1. Signifi-
cantly, although 53BP1 creates a block to all resection and its
loss allows unregulated resection and alt-NHEJ, the interplay
between BRCA1 and 53BP1 promotes resection-dependent
c-NHEJ (Figure 7D).
An important distinction between factors that initiate resection
versus Artemis is that X-ray-induced DSBs are repaired without
the initiating factors but remain unrepaired without Artemis.
Thus, we propose that Artemis does not process the primary
IR-induced DSBs as hypothesized previously (Riballo et al.,
2004) but, rather, resolves intermediate structures that arise
following resection by Exo1/EXD2 or Mre11 exonuclease,
respectively. An interesting (although not the only) model is
that 50 or 30 ssDNA overhangs are captured by a channel in
DNA-PKcs, identified by structural studies, that is of the required
size to allow passage of ssDNA but not double-stranded DNA
(dsDNA) (Leuther et al., 1999; Williams et al., 2008, 2014). This
could create a hairpin-like end necessitating Artemis for cleav-
age (Figure S7C). Our observation that Artemis is required for
pRPA focus formation suggests that RPA binding only occurs af-
ter such cleavage. This model is appealing because it explains
the absolute requirement for Artemis in removing trapped resec-
tion intermediates and reflects its role in cleaving hairpin interme-
diates during V(D)J recombination (Ma et al., 2002). The model is
consistent with biochemical studies and explains why Ku and
DNA-PKcs are required for efficient Artemis activity (Chang
et al., 2015). Moreover, Artemis’s endonucleolytic function
downstream of initiation is consistent with the observed loss of
nucleotides during resection-dependent c-NHEJ.
Micro-homology mediated end-joining (MMEJ) is a DSB re-
joining process defined by short micro-homology usage (McVey
and Lee, 2008). MMEJ is often taken to be synonymous with alt-
NHEJ. However, the rejoining step of MMEJ could occur by
c-NHEJ or alt-NHEJ. Our findings suggest that resection-depen-682 Molecular Cell 65, 671–684, February 16, 2017dent c-NHEJ represents MMEJ because alt-NHEJ does not sub-
stantially contribute to DSB rejoining or translocation formation
in G1 human cells, functioning only in the absence of Ku or
53BP1 (Figure 7D). Alt-NHEJ has a greater function in rodent
cells, where it contributes to translocations, potentially because
of lower DNA-PK levels (Ghezraoui et al., 2014). Importantly,
resection-dependent c-NHEJ significantly contributes to IR-
induced translocations in human cells, consistent with the contri-
bution of CtIP after DSB induction by restriction enzymes (Zhang
and Jasin, 2011). Thus, our finding that CtIP (which was hitherto
believed to promote alt-NHEJ) functions during c-NHEJ unifies
these apparently contradicting notions. Thus, we propose that
the slow component of DSB repair in G0/G1 phase human cells
can result in MMEJ, with rejoining involving c-NHEJ and not
alt-NHEJ.
In summary, we have identified and characterized a resection-
dependent c-NHEJ process and revealed distinctions from the
resection process during HR. Resection is activated in G1 by
Plk3 which phosphorylates CtIP at Ser327, mediating its binding
to Brca1, and is then executed by Exo1, EXD2, and Mre11
exonuclease. Mre11’s endonuclease function, which initiates
resection during HR in G2, is not involved. Finally, Artemis func-
tions as an endonuclease downstream of the executing exonu-
cleases to complete the process. DNA-PK coordinates the
completion of repair by c-NHEJ. Thus, resection-dependent
c-NHEJ uses the same toolbox of resection factors involved in
HR but orchestrates them to be compatible with an end-joining
process (Figure 7C).STAR+METHODS
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STAR+METHODSKEY RESOURCES TABLEREAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Rabbit-anti-53BP1 Bethyl A300-272A
Mouse-anti-53BP1 (clone BP13) Millipore #05-726




Mouse-anti-Brca1 (D-9) Santa Cruz sc-6954
Rabbit-anti-Brca1 (C-20) Santa Cruz sc-642
Mouse-anti-Brca1_MS13 Abcam ab16781
Mouse-anti-BrdU (3D4) BD PharMingen 555627
Mouse-anti-CD4-FITC Biolegend 100510
Mouse-anti-CtIP (E-2) Santa Cruz sc-48415
Rabbit-anti-CtIP Bethyl A300-488A
Mouse-anti-CtIP (D-4) Santa Cruz sc-271339
Rabbit-anti-pCtIP (Ser327) Phosphosolutions N/A
Rabbit-anti-CDT1 Abcam ab202067
Rabbit-anti-DNA2 Abcam ab 96488
Rabbit-anti-DNA-PKcs Novus Biologicals NB100-658
Rabbit-anti-EXD2 Sigma HPA005848
Mouse-anti-Exo1 Abcam ab3307
Mouse-anti-Flag (M2) Sigma F3165
Rabbit-anti-GAPDH (FL-335) Santa Cruz sc-25778
Mouse-anti-GFP Roche 11 814 460 001
Rabbit-anti-GFP Santa Cruz sc-8334
Mouse-anti-phospho-Histone H2A.X (Ser139) Millipore # 05-636
Rabbit-anti-phospho-Histone H2A.X (Ser139) Abcam ab81299
Mouse-anti-HA tag (HA.C5) Abcam ab18181
Mouse-anti-Ku70 (A-9) Santa Cruz sc-5309
Mouse-anti-Ku80 (111) Abcam ab79220
Mouse-anti-Lig1 (1A9) Santa Cruz sc-47703
Mouse-anti-Lig3 Santa Cruz sc-56089
Rabbit-anti-Lig4 Acris SP1275
Mouse-anti-cMyc (9E10) Santa Cruz sc-40
Rabbit-anti-Plk3 Abcam ab33119
Rabbit-anti-tRFP Evrogen AB233
Rabbit-anti-RPA32/RPA2 (phosphoT21) Abcam ab109394
Rabbit-anti-I-SceI (FL-86) Santa Cruz sc-98269
Mouse-anti-alpha-Tubulin (TU-02) Santa Cruz sc- 8035
Goat-anti-mouse IgG-HRP Santa Cruz sc-2031
Goat-anti-rabbit IgG-HRP Santa Cruz sc-2030
Goat-anti-mouse IgG AlexaFluor 488 Molecular Probes A11001
Goat-anti-mouse IgG AlexaFluor 594 Molecular Probes A11005
Goat-anti-rabbit IgG AlexaFluor 488 Molecular Probes A11008
Goat-anti-rabbit IgG AlexaFluor 594 Molecular Probes A11012
(Continued on next page)
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Chemicals, Peptides, and Recombinant Proteins
Plk inhibitor GW 843682X Tocris Bioscience 2977
DNA-PK inhibitor Nu7441 Tocris Bioscience 3712
EdU baseclick BCN-001
BrdU BD Bioscience 550891
DAPI Sigma-Aldrich D9542
PARP inhibitor PJ34 Calbiochem 528151
Mre11 (endo) inhibitor (PFM01) Shibata et al., 2014 N/A
Mre11 (exo) inhibitor (PFM39) Shibata et al., 2014 N/A
Dynabeads Protein G Thermo Scientific 10004D
Anti-rat IgG MicroBeads Miltenyi Biotec 130-048-501
Nocodazole Sigma-Aldrich M1404
KaryoMAX Colcemid GIBCO 15212012
Polyethylenglycol (PEG) Roche 10783641001
RNase-A Sigma-Aldrich R4875
Thymidine Sigma-Aldrich T1895-1G
KOD Hot Start DNA Polymerase Novagen 71086-4
Critical Commercial Assays
Effectene Transfection Reagent QIAGEN 301425
jetPEI Transfection Reagent Polyplus 13-101-10
HiPerFect Transfection Reagent QIAGEN 301707
PEI Sigma-Aldrich 408727-7
EdU-Click Kit (Cy5) baseclick BCK-EDU-647-1
peqGOLD Xchange Plasmid maxi-EF Kit peqlab 12-7404-01
MACS separation column Miltenyi Biotec 130-042-201
MasterPure Complete DNA & RNA Purification Epicenter MC85200
PureLink Genomic DNA Mini Kit Thermo Scientific K1820-01
FISH XCP Mix MetaSystems D-0328-200-MC
LumiLight Western Blotting Substrate Roche 12015200001
WesternBright Quantum Advansta 541015
WesternBright Sirius Advansta 541021
Experimental Models: Cell Lines
Human: 82-6 hTert Riballo et al., 2004 N/A
Human: CJ179 hTert Riballo et al., 2004 N/A
Human: HeLa-S3 ATCC ATCC-CCL-2.2
Human: GC92 Rass et al., 2009 N/A
Mouse: MEF Brca1-wt Shakya et al., 2011 N/A
Mouse: MEF Brca1-DBRCT Shakya et al., 2011 N/A
Human: 2BN hTert Shibata et al., 2011 N/A
Human: 411BR hTert Jeggo Lab (Sussex) N/A
Human: HeLa pGC Barton et al., 2014 N/A
Experimental Models: Organisms/Strains
DH5a E. coli This paper N/A
Recombinant DNA
pGEM-T Easy Vector Promega A1360
pUC19 New England Biolabs N3041S
pEGFP_C1 Clontech 632470
tRFP Jeggo Lab (Sussex) N/A
(Continued on next page)
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siRNA-resistant pEGFP-CtIP Barton et al., 2014 N/A
siRNA-resistant pClneo-cMyc-Artemis Beucher et al., 2009 N/A
siRNA-resistant Flag-Plk3 Barton et al., 2014 N/A
siRNA-resistant Flag-Brca1 Shakya et al., 2011 N/A
siRNA-resistant HA-53BP1 Jeggo Lab (Sussex) N/A





LAS AF Lite Leica N/A
AxioVision V4.6.3.0 Zeiss Imaging Solutions N/A
ImageJ Open Source N/A
ChemiCapt Vilber Lourmat N/A
FusionCapt Advance FX7 Vilber Lourmat N/A
Other
X-ray tube: MCN 165/796704 Philips N/A
Microscope: Axiovert 200M Zeiss N/A
Microscope: Image Z.2 Zeiss N/A
Confocal laser scanning microscope: TCS SP5 II Leica N/A
Chemiluminescence detection: ChemiSmart 5000 Vilber Lourmat N/A
Chemiluminescence detection: Fusion FX Vilber Lourmat N/ACONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for reagents may be directed to, and will be fulfilled by the Lead Contact, Markus Lo¨brich (lobrich@
bio.tu-darmstadt.de).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cell Lines and Cell Culture
Cell lines used were control 82-6 hTert (Riballo et al., 2004), Artemis-deficient CJ179 hTert (Riballo et al., 2004), HeLa (ATCC), GC92
(Rass et al., 2009), Brca1-wt and Brca1-DBRCTMEFs (Shakya et al., 2011), XLF-deficient 2BN hTert (Shibata et al., 2011), hypomor-
phic Lig4-mutated 411Br hTert (Jeggo Lab), and HeLa pGC (Barton et al., 2014). Cells were tested for mycoplasm contamination by
PCR, HeLa cells were authenticated by ATCC. HeLa, GC92 cells and MEFs were cultured in DMEM with 10% FCS and 1% NEAA,
82-6, CJ179, 411Br and 2BN cells in MEM with 20% FCS, 1% NEAA. All cells were maintained at 37C in a 5% CO2 incubator.
Bacterial Strains
Competent DH5a E.coli were used for transformations.
METHOD DETAILS
Generation of Artemis KO Cells with CRISPR/Cas9
Vectors encoding Artemis guide RNAs (see Key Resources Table) were used. GC92 cells were transfected with the Artemis gRNA
plasmids, a Cas9 and a EGFP plasmid using PEI following the manufacturer’s instructions. Single GFP-positive cells were sorted
into 96 well plates and tested for knockdown on a protein level using immunoblotting. Genomic DNA was extracted from potential
KO cells with PureLink Genomic DNA Mini Kit and PCR was performed with KOD Hot Start DNA Polymerase to amplify the tar-
geted regions. PCR products were cloned into pGEM-T Easy Vector and transformed into DH5a competent E. coli. Isolated
plasmid DNA of at least 10 colonies from each transformation were sent for sequencing to ensure frameshift mutation in the tar-
geted region.Molecular Cell 65, 671–684.e1–e5, February 16, 2017 e3
RNA Interference and Plasmid Transfection
SiRNA transfection of HeLa, 82-6, CJ179, and GC92 cells andMEFs was carried out using HiPerFect Transfection Reagent following
the manufacturer’s instructions. 53BP1 (25nM), Artemis (15 nM), BLM (50nM), Brca1 (25 nM), CtIP (50 nM), DNA2 (20nM), DNA-PKcs
(15 nM), EXD2 (25nM), Exo1 (20 nM), Ku70 (25 nM), Ku80 (25 nM), Lig1 (25 nM), Lig3 (25 nM), Lig4 (20 nM), and Plk3 (25 nM) siRNAs
were used (target sequences are listed in the Key Resources Table). Experiments were either performed 48 hr after transfection or
after 72 hr with an additional siRNA transfection after 24 hr. In complementation studies, the endogenous protein was depleted by
siRNA in HeLa, MEF, 82-6, CJ179 or GC92 cells and 24 hr after siRNA transfection, cells were transfected with various plasmids (see
Key Resources Table) using Effectene or jetPEI following the manufacturer’s instructions. HeLa cells for immunoprecipitation exper-
iments were transfected with PEI following the manufacturer’s instructions. For I-SceI-transfection, GC92 or HeLa pGC cells were
transfected using jetPEI following the manufacturer’s instructions.
IR and Chemical Treatment
X-IR was performed at 90 kV and 19mA. A 241Am source was used for a-IR. Chemical inhibitors were added 1 hr prior to IR andmain-
tained during repair incubation. The Plk inhibitor GW843682X (IC50 values of 2.2 and 9.1 nM for Plk1 and Plk3, respectively), the DNA-
PK inhibitor Nu7441, the PARP inhibitor PJ34, theMre11 (endo) inhibitor and theMre11 (exo) inhibitor (Shibata et al., 2014) were used
at concentrations of 0.5, 7.5, 15, 50, and 300 mM.
Chromosomal Analysis
For the analysis of translocations and chromosome breaks in G1, exponentially growing or confluent 82-6 or CJ179 fibroblasts
were irradiated. To prevent progression of G2-irradiated cells into G1 during repair incubation, cells were treated with nocodazole
(100 ng/ml) prior to IR. After repair incubation, cells were mixed at a ratio of 1:1 with mitotic HeLa cells (enriched by treatment
with colcemid for 20 h). Cell fusion was mediated by Polyethylenglycol (PEG). For FISH experiments whole chromosome probes
1, 2 and 4 were used and the staining was performed following the manufacturer’s protocol (MetaSystems). Pictures of the chromo-
somes were acquired by using an Axioplan2 microscope with an EC Plan Neofluar (63x) (Zeiss) andMetafer software (MetaSystems).
Only the stained chromosomes were analyzed.
Protein Extracts, Immunoprecipitation, and Immunoblotting
Knockdown efficiencies and expression of exogenous plasmids were confirmed by immunoblotting. For immunoprecipitation, 2 mg
antibodies (see Key Resource Table) were linked to Dynabeads Protein G, washed three times in 0.1%BSA/PBS and then incubated
with the cell extract at 4C for 2 hr. After immunoblotting, the membrane was blocked in 5% low fat milk or 5% BSA in TBS/0.1%
Tween20. Immunoblotting was carried out in TBS/0.1% Tween20/1% low fat milk or 5% BSA over night at 4C, followed by
HRP-conjugated secondary antibody incubation in PBS/0.1% Tween20/1% low fat milk or 5% BSA for 1 hr. Immunoblots were
developed using LumiLight immunoblotting substrate or WesternBright Quantum or Sirius. Signal detection was performed with
ChemiSmart5000 or Fusion FX. Antibodies are listed in the Key Resources Table.
Immunofluorescence
Cells were grown on glass coverslips for X-IR and on Mylar foil for a-IR. The thymidine analog EdU and nocodazole (100 ng/ml) were
added 30 min prior to IR and cells were fixed and stained. EdU incorporation was detected with an EdU-Click kit. For BrdU foci anal-
ysis, cells were pre-extracted for 10min with 0.5%Triton X-100. Cells were examined with a Zeissmicroscope andMetafer software.
For each foci counting experiment at least 40 cells were evaluated. For Ku80 foci staining, cells were pre-extracted and stained as
previously described (Chanut et al., 2016). Additionally, after the secondary antibody staining, cells were fixed with 2% PFA for
10 min. For image acquisition Z stacks were obtained with a confocal laser scanning microscope using a 100x immersion objective.
Co-localization of Ku80 and pRPA or Rad51 foci was analyzed using LAS AF Lite software (dx < 20 nm for co-localization of signal
intensity in line profile). Antibodies are listed in the Key Resources Table.
Reporter Assays
HeLa pGC cells containing an HR substrate were transfected with a I-SceI-plasmid 24 hr after seeding and treated with inhibitors.
GC92 cells containing an NHEJ substrate were transfected with siRNA. For complementation studies, cells were transfected with
constructs 24 hr after seeding. 48 hr after seeding, cells were transfected with a I-SceI-expressing plasmid and either treated
with an inhibitor or transfected again with siRNA. After 72 hr the cells were fixed and stained. Up to 10,000 cells were analyzed
per sample for either GFP (HeLa pGC cells) or CD4 (for GC92) positive cells with amicroscope (Axiovert 200M) andMetafer software.
Antibodies are listed in the Key Resources Table.
Sequence Analysis in NHEJ Reporter Assay
GC92 cells were dissociated with 50 mM EDTA in PBS and stained with 1.5 mg rat-a-CD4-FITC antibody for 30 min at 4C. After
washing, cells were incubated 15 min at 4C with goat-a-rat microbeads. Then, the CD4-positive GC92 cells were separated ande4 Molecular Cell 65, 671–684.e1–e5, February 16, 2017
enriched by using a miniMACS column. After purification of DNA with MasterPure Complete DNA & RNA Purification, PCR was per-
formed using the primers listed in the Key Resources Table. To isolate the individual clones, PCR products were cloned into pUC19
and sequenced (MWG Eurofins).
Anti-pSer327 Antibody Preparation
Phospho-specific antibodies were produced in rabbits against CtIP-pSer327 (custom antibody service from Phosphosolutions). The
antigens were synthetic phospho-peptides corresponding to amino acids surrounding the phosphorylated Ser327 in the human CtIP
sequence. The resulting solution of purified antibody was stored at 20C.
Cell Synchronization and Flow Cytometry
Proliferating HeLa cells were treated with 2 mM thymidine for 16 hr, released in thymidine-free medium for 10 hr and again pulse-
treated with thymidine for 14 hr. Cells were again released in fresh medium without thymidine for 18 hr to obtain G1 cells. Cell syn-
chronization was controlled by propidium iodide and BrdU flow cytometry analysis.
QUANTIFICATION AND STATISTICAL ANALYSIS
All data were derived from at least n = 3 replicates for foci analysis and chromosomal studies, or from at least n = 4 biological
replicates for the NHEJ and HR reporter assays. Column plots show the mean value and boxplots were created with
SigmaPlot12.0. Background foci/chromosome breaks/chromosome translocations were subtracted from themean values. The error
bars in the column plots show the SEM between the experiments. p values in column and line plots originate from Student’s t test.
They compare all cells analyzed in foci and chromosomal experiments and compare the mean data in the NHEJ and HR reporter
assay (*, p < 0.05; **, p < 0.01; ***, p < 0.001). p values in boxplots originate from Mann-Whitney U test analyzed with SigmaPlot12.0.Molecular Cell 65, 671–684.e1–e5, February 16, 2017 e5
